HG AS 293 (61.2%) | LG AS 186 (38.8%) | Total 479 | p value | |
---|---|---|---|---|
Female n (%) | 137 (46.8%) | 82 (43.9%) | 219 (45.6%) | 0.5 |
Age median (IQR) | 80 (77–83) | 80 (78–83) | 80 (77–83) | ns |
BMI | 27.6 (26–31) | 31.2 (29.1–35.1) | 29.1 (26.2–31.2) | 0.04 |
EUROII median (SD) | 26.6 (16.8) | 28.2 (7.4) | 27.1 (11) | 0.07 |
Sts score | 5.1 (4.8) | 9.6 (14) | 6.8 (8) | 0.04 |
DM n (%) | 133 (45.5%) | 96 (51.3%) | 229 (47.8%) | 0.2 |
CLD n (%) | 37 (12.6%) | 36 (19.3%) | 73 (15.2%) | 0.06 |
CKD n (%) | 69 (23.5%) | 58 (31%) | 127 (26.5%) | 0.07 |
Stroke n (%) | 15 (5.1%) | 17 (9.1%) | 32 (6.7%) | 0.07 |
CABG n (%) | 11 (3.8%) | 15 (8%) | 26 (5.4%) | 0.04 |
Atrial fibrillation | 84 (28.7%) | 69 (36.9%) | 153 (31.9%) | 0.09 |
NYHA III/IV n (%) | 178 (60.8%) | 127 (67.8%) | 304 (63.5%) | 0.053 |